日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Monitoring systemic immune responses to checkpoint inhibition in breast cancer reveals host responses and mechanisms of resistance

监测乳腺癌中针对免疫检查点抑制剂的系统性免疫反应,可以揭示宿主反应和耐药机制。

Hanna, Ann; Sun, Xiaopeng; Sheng, Quanhu; Gonzalez-Ericsson, Paula I; Wescott, Elizabeth C; Taylor, Brandie C; Marshall, Jacey L; Opalenik, Susan R; Toren, Abigail L; Sanchez, Violeta; Fielder, Carly M; Sanders, Melinda E; Balko, Justin M

The Impact of JAK1 Pathogenic Variants and MHC-I Expression on Response to Immune Checkpoint Inhibition in Endometrial Cancer

JAK1致病变异和MHC-I表达对子宫内膜癌免疫检查点抑制剂治疗反应的影响

Carballo, Erica V; Gonzalez-Ericsson, Paula; Lehmann, Brian D; Taylor, Brandie C; Wulfkuhle, Julia D; Ocampo, Andres; Gallagher, Rosa I; Huang, Dandi S; Maxey, Christina; Steele, Julia A; Kleinberg, Katherine; Sun, Xiaopeng; Marshall, Jacey L; Sanchez, Violeta; Opalenik, Susan R; Petricoin, Emanuel; Rimel, B J; Balko, Justin M; Penn, Courtney A

A phase Ib/II trial of atezolizumab with cobimetinib or idasanutlin in metastatic estrogen receptor positive breast cancer

一项针对转移性雌激素受体阳性乳腺癌患者的阿特珠单抗联合考比替尼或伊达沙努林的Ib/II期临床试验

Mezzanotte-Sharpe, Jessica; Taylor, Brandie C; Gonzalez-Ericsson, Paula I; Sanchez, Violeta; Ocampo, Andres A; Marshall, Jacey L; Steele, Julia A; Sanders, Melinda E; Mayer, Ingrid A; Balko, Justin M; Kennedy, Laura C

Peripheral blood gene expression signatures of systemic immunity predict tumor microenvironment biology and therapeutic response in breast cancer.

外周血基因表达特征反映全身免疫,可预测乳腺癌肿瘤微环境生物学和治疗反应

Balko Justin, Sun Xiaopeng, Hanna Ann, Ocampo Andres, Taylor Brandie, Marshall Jacey, Steele Julia, Axelrod Margaret, Wescott Elizabeth, Opalenik Susan, DeMichele Angela, Esserman Laura, Liu Minetta, Nanda Rita, Wolf Denise, Swigart Lamorna Brown, Hirst Gillian, Van 't Veer Laura, Xu Yaomin